AlphaCore Capital LLC Takes Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

AlphaCore Capital LLC bought a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 30,000 shares of the pharmacy operator’s stock, valued at approximately $269,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Charles Schwab Investment Management Inc. boosted its position in shares of Walgreens Boots Alliance by 43.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock worth $98,284,000 after acquiring an additional 3,329,857 shares during the last quarter. Thompson Siegel & Walmsley LLC raised its stake in Walgreens Boots Alliance by 98.8% during the second quarter. Thompson Siegel & Walmsley LLC now owns 6,021,126 shares of the pharmacy operator’s stock worth $72,826,000 after purchasing an additional 2,992,648 shares during the period. Newport Trust Company LLC acquired a new position in shares of Walgreens Boots Alliance in the 2nd quarter valued at $31,028,000. Swedbank AB purchased a new stake in shares of Walgreens Boots Alliance during the 1st quarter valued at $16,365,000. Finally, Philip James Wealth Mangement LLC acquired a new stake in shares of Walgreens Boots Alliance during the 3rd quarter worth $5,252,000. 58.59% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Stock Up 0.4 %

WBA opened at $8.27 on Friday. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $27.05. The company has a quick ratio of 0.37, a current ratio of 0.68 and a debt-to-equity ratio of 0.67. The firm’s fifty day moving average price is $9.15 and its 200 day moving average price is $11.65.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.36 by $0.03. The business had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The company’s revenue for the quarter was up 5.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.67 EPS. On average, equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be issued a $0.25 dividend. The ex-dividend date is Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 12.09%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is -9.99%.

Analyst Ratings Changes

A number of equities research analysts have issued reports on WBA shares. Morgan Stanley lowered their price target on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a research report on Friday, October 11th. JPMorgan Chase & Co. dropped their target price on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a research report on Friday, August 30th. Barclays raised their price target on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a report on Wednesday, October 16th. TD Cowen decreased their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a research note on Tuesday, October 22nd. Finally, Bank of America cut their target price on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a research note on Wednesday, September 4th. Four analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, Walgreens Boots Alliance has an average rating of “Hold” and a consensus target price of $12.88.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.